Cargando…
Large-scale gene expression analysis reveals robust gene signatures for prognosis prediction in lung adenocarcinoma
Lung adenocarcinoma (LUAD) is the leading cause of cancer-related death worldwide. High mortality in LUAD motivates us to stratify the patients into high- and low-risk groups, which is beneficial for the clinicians to design a personalized therapeutic regimen. To robustly predict the risk, we identi...
Autores principales: | Songyang, Yiyan, Zhu, Wei, Liu, Cong, Li, Lin-lin, Hu, Wei, Zhou, Qun, Zhang, Han, Li, Wen, Li, Dejia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6553445/ https://www.ncbi.nlm.nih.gov/pubmed/31198635 http://dx.doi.org/10.7717/peerj.6980 |
Ejemplares similares
-
Identification of lung adenocarcinoma subtypes and predictive signature for prognosis, immune features, and immunotherapy based on immune checkpoint genes
por: Hua, Linbin, et al.
Publicado: (2023) -
Prognostic Signature for Lung Adenocarcinoma Patients Based on Cell-Cycle-Related Genes
por: Jiang, Wei, et al.
Publicado: (2021) -
Development and Validation of a Robust Ferroptosis-Related Prognostic Signature in Lung Adenocarcinoma
por: Zhang, Anran, et al.
Publicado: (2021) -
Identification of a glycolysis- and lactate-related gene signature for predicting prognosis, immune microenvironment, and drug candidates in colon adenocarcinoma
por: Liu, Cong, et al.
Publicado: (2022) -
An Aging-Related Gene Signature-Based Model for Risk Stratification and Prognosis Prediction in Lung Adenocarcinoma
por: Xu, Qian, et al.
Publicado: (2021)